» Articles » PMID: 2800976

Halothane-induced Variability in the Neuromuscular Transmission of Patients with Myasthenia Gravis

Overview
Specialty Anesthesiology
Date 1989 Jul 1
PMID 2800976
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the present clinical study was to explore the skeletal muscle mechano (MMG)- and electromyographic (EMG) responses during halothane/oxygen/air anaesthesia in patients with myasthenia gravis (MG) compared with patients with normal neuromuscular transmission. The majority of MG-patients had a significant decremental response of the evoked muscle action potentials to a train-of-four (TOF) stimulation during halothane exposure (mean decrease of train-of-four ratio was 33% during the highest mean halothane concentration of 1.9 MAC). An excellent correlation was found between MMG- and EMG-measurements (r2 = 0.878, P less than 0.001). However, marked individual variations in the neuromuscular response to halothane were seen. Neither preoperative muscle fatigability nor acetylcholine receptor antibodies predicted the decremental muscle responses produced by halothane among MG-patients. The increased presence of HLA-B8 among myasthenics with halothane-suppressed muscle responses after TOF stimulation could be demonstrated (P less than 0.01).

Citing Articles

Use of ProSeal(®) LMA and thoracic epidural in myasthenia patients for trans-sternal thymectomy: A case series.

Simon B, Nair S, Paik G, Nyi K Indian J Anaesth. 2015; 59(7):444-6.

PMID: 26257421 PMC: 4523969. DOI: 10.4103/0019-5049.160962.


Sevoflurane-induced sensitivity of neuromuscular function in a patient with myasthenia gravis in true remission.

Takeda J, Ohnishi Y, Koitabashi T, Fukushima K J Anesth. 2013; 11(2):150-2.

PMID: 23839689 DOI: 10.1007/BF02480079.


Neuromuscular effects of sevoflurane in patients with myasthenia gravis.

Morita T, Tsukagoshi H, Kurosaki D, Sugaya T, Yoshikawa D, Shimada H J Anesth. 2013; 10(3):157-62.

PMID: 23839618 DOI: 10.1007/BF02471383.


Anaesthetic considerations in paediatric myasthenia gravis.

Masters O, Bagshaw O Autoimmune Dis. 2011; 2011:250561.

PMID: 21961057 PMC: 3179867. DOI: 10.4061/2011/250561.


Neuromuscular effects of sevoflurane in a patient with Myasthenia Gravis.

Nishi M, Nakagawa H, Komatsu R, Natsuyama T, Tanaka Y J Anesth. 1993; 7(2):237-9.

PMID: 15278481 DOI: 10.1007/s0054030070237.